Symbol="TVTX"
AssetType="Common Stock"
Name="Travere Therapeutics Inc"
Description="Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development and commercialization of therapies for the treatment of rare diseases. The company is headquartered in San Diego, California."
CIK="1438533"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="777 THIRD AVENUE 22ND FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1005189000"
EBITDA="-258668992"
PERatio="None"
PEGRatio="None"
BookValue="1.554"
DividendPerShare="0"
DividendYield="0"
EPS="-4.55"
RevenuePerShareTTM="3.318"
ProfitMargin="-1.36"
OperatingMarginTTM="-1.327"
ReturnOnAssetsTTM="-0.247"
ReturnOnEquityTTM="-2.251"
RevenueTTM="226054000"
GrossProfitTTM="-31354000"
DilutedEPSTTM="-4.55"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.102"
AnalystTargetPrice="26.93"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="5.56"
PriceToBookRatio="11.94"
EVToRevenue="5.17"
EVToEBITDA="-4.999"
Beta="0.417"
num_52WeekHigh="28.38"
num_52WeekLow="12.57"
num_50DayMovingAverage="15.35"
num_200DayMovingAverage="18.85"
SharesOutstanding="75011000"
DividendDate="None"
ExDividendDate="None"
symbol="TVTX"
open="13.21"
high="13.34"
low="12.99"
price="13.19"
volume="1090192.00"
latest_trading_day="2023-08-30"
previous_close="13.12"
change="0.07"
change_percent="0.5335%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="1200115"
Change_recent_avg="-0.03"
Delta_recent_avg="0.75"
Variance_recent_avg="0.38"
Change_ratio_recent_avg="-0.23"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="1114"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0147.jpeg"
image_negative_thumbnail_id_2="1095"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0128.jpeg"
image_neutral_thumbnail_id_1="593"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_neutral_thumbnail_id_2="591"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_positive_thumbnail_id_1="635"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0073.jpeg"
image_positive_thumbnail_id_2="993"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
